Octreotide Acetate

CAS 83150-76-9 20 FDA-DMF suppliersPeptide

Overview

Octreotide Acetate is a synthetic octapeptide that mimics natural somatostatin pharmacologically, inhibiting the secretion of several hormones. It is primarily used in the treatment of acromegaly and severe cases of diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide tumors.

API suppliers (14)

Suppliers of Octreotide Acetate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • TAPI NL BV1 active DMF
  • TAPI NL BV1 active DMF
  • BCN PEPTIDES SASpain1 active DMF
  • CHEMI SPAItaly1 active DMF
  • BCN PEPTIDES SASpain1 active DMF
  • TAPI NL BV1 active DMF
  • BCN PEPTIDES SASpain1 active DMF
  • CHEMI SPAItaly1 active DMF
  • POLYPEPTIDE LABORATORIES INCUnited States1 active DMF
  • TAPI NL BV1 active DMF
  • BCN PEPTIDES SASpain1 active DMF
  • CHEMI SPAItaly1 active DMF
  • Wockhardt LimitedIndia
  • Navesta Pharmaceuticals (Pvt) Ltd.Sri Lanka

Therapeutic areas

EndocrinologyOncologyGastroenterology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.